Risk of Reinfection From SARS-CoV-2 – An Update of an Antibody Response Following SARS-CoV-2 Infection and Implications for Immunity: A Living Rapid Review [Internet]

Mark Helfand; Celia Fiordalisi; Jack Wiedrick; Katrina L. Ramsey; Charlotte Armstrong; Emily Gean; Kara Winchell; Irina Arkhipova-Jenkins

doi:10.23970/AHRQEPCCOVIDIMMUNITY2

Risk of Reinfection From SARS-CoV-2 – An Update of an Antibody Response Following SARS-CoV-2 Infection and Implications for Immunity: A Living Rapid Review [Internet]

Review

Rockville (MD): Agency for Healthcare Research and Quality (US); 2022 Jan. Report No.: 21(22)-EHC034.

AHRQ Rapid Evidence Products.

Authors

Mark Helfand¹, Celia Fiordalisi¹, Jack Wiedrick², Katrina L. Ramsey², Charlotte Armstrong¹, Emily Gean¹, Kara Winchell¹, Irina Arkhipova-Jenkins¹

Affiliations

¹ Scientific Resource Center to the AHRQ EPC Program
² Oregon Health & Science University Biostatistics & Design Program

No abstract available

Publication types

Review

Grants and funding

Role of the Funding Source: Funding for this review was provided by AHRQ. The funding source assigned the topic and provided comments on draft manuscripts, but was not involved in data collection, analysis, manuscript preparation, or addressing comments from reviewers.